Prostatic Artery Embolization, or PAE, is a non-surgical treatment to decrease the size of the prostate with the injection of micro-particles in to the prostatic arteries. This allows for the reduction in the size of the prostate, and symptoms from Benign Prostatic Hyperplasia (BPH), without the risks of impotence or incontinence. The procedure is performed without placement of anything through the urethra/penis.
 

Aquablation therapy is a unique, next-generation BPH treatment that is changing the tradeoff between symptom relief and side effects. Patients can get significant symptom relief with less risk of side effects that impact their quality of life compared to the surgical gold-standard TURP.  

Powered by convective water vapor energy, the Rezūm System delivers targeted, controlled doses of the stored thermal energy in water vapor directly to the region of the prostate gland with the obstructive tissue causing the lower urinary tract symptoms secondary (LUTS) to benign prostatic hyperplasia (BPH).

The UroLift ® System is a new, minimally invasive approach to treating BPH for patients looking for an alternative to drug therapy or more invasive surgery. The UroLift System is a straightforward procedure that utilizes tiny implants to lift and hold the enlarged prostate tissue out of the way so it no longer blocks the urethra. There is no cutting, heating or removal of prostate tissue.